Hyperlipidemia due to Hepatic Triacylglycerol Lipase Deficiency: A Patient Guide
At a Glance
Hepatic lipase deficiency is a rare inherited condition caused by changes in both copies of the LIPC gene. It can produce unusually high cholesterol and triglycerides, so care combines a personalized diet, physical activity, medicines when needed, and monitoring for pancreatitis and heart risk.
Hyperlipidemia due to hepatic triacylglycerol lipase deficiency, often called hepatic lipase deficiency, is an exceptionally rare genetic condition that fundamentally changes how your body manages fats. It usually occurs when a person inherits two pathogenic variants in the LIPC gene, one from each parent, which markedly reduce or abolish the activity of the hepatic lipase enzyme [1][2]. Under normal circumstances, this enzyme acts like a precision tool, “trimming” and reshaping fat particles such as triglycerides and phospholipids to keep them in balance. Without it, these fats can accumulate in the bloodstream, leading to an unusual and variable pattern of high cholesterol and triglycerides [3][4].
The way this condition behaves can be unpredictable, with lipid levels varying significantly even among people with the same genetic diagnosis. This variability is often influenced by “secondary factors” like diet, weight, and other health conditions that can unmask or worsen the underlying genetic deficiency [2][5]. Living with this condition requires a focus on monitoring for two primary health concerns: the risk of acute pancreatitis (inflammation of the pancreas) when triglyceride levels are severely elevated, and assessing your cardiovascular system for general risk factors that can lead to the buildup of arterial plaque [6][7].
Managing this rare diagnosis is a lifelong process that centers on specialized lifestyle choices and medical oversight. While another enzyme, lipoprotein lipase, handles much of your dietary fat processing, an individualized diet—focusing on heart-healthy choices or limits supervised by a dietitian—and regular physical activity become the cornerstone of your health strategy [5]. While there is no single drug designed specifically for this enzyme deficiency, doctors use a combination of triglyceride-lowering medications and heart-protective therapies to manage the condition effectively [8][9].
While a diagnosis of such a rare disorder can feel overwhelming, working closely with a specialized medical team can help you take proactive steps to manage your lipid levels and reduce your risks. Understanding the biology of your condition is the first step toward managing your long-term health and well-being [10].
In this guide
5 chapters
Understanding Hepatic Lipase Deficiency
Learn how hepatic lipase deficiency affects cholesterol and triglycerides, how LIPC variants cause it, pancreatitis risk, and individualized monitoring and care.
How Hepatic Lipase Deficiency is Diagnosed
Learn how hepatic lipase deficiency is diagnosed using lipid patterns, LIPC genetic testing, enzyme activity tests, and evaluation for look-alike conditions.
Understanding Your Risks and Complications
Learn how hepatic lipase deficiency affects pancreatitis risk and heart health, including triglyceride thresholds, warning symptoms, triggers, and pregnancy planning.
Managing Your Lipid Levels
Learn how hepatic lipase deficiency is managed with diet, exercise, medicines, and monitoring to lower triglycerides and reduce pancreatitis and heart risks.
Long-Term Monitoring and Your Care Team
Learn how to monitor hepatic lipase deficiency, including lipid tests, apoB, care-team specialists, follow-up timing, and emergency pancreatitis warning signs.
Common questions in this guide
What causes hepatic lipase deficiency?
Why can cholesterol and triglyceride levels vary with this condition?
Does hepatic lipase deficiency increase the risk of pancreatitis?
How is hepatic lipase deficiency treated?
Can hepatic lipase deficiency affect heart health?
Can diet and weight change the effects of hepatic lipase deficiency?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Hyperlipidemia due to hepatic triacylglycerol lipase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How does my specific genetic variant in the LIPC gene compare to those found in other reported cases?
- 2.What are the primary goals for my triglyceride and cholesterol levels given my unique genetic profile?
- 3.Are there specialized clinics or research centers that focus on rare hepatic lipase disorders where I can seek expert consultation?
- 4.What specific signs of pancreatitis should my family and I be aware of as 'red flags' for immediate action?
References
References (10)
- 1
Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.
Kobayashi J, Miyashita K, Nakajima K, Mabuchi H
Journal of atherosclerosis and thrombosis 2015; (22(10)):1001-11 doi:10.5551/jat.31617.
PMID: 26194979 - 2
Hypertriglyceridemia Induced Acute Pancreatitis Caused by a Novel LIPC Gene Variant in a Pediatric Patient.
Balanescu L, Cardoneanu A, Stanciu G, et al.
Children (Basel, Switzerland) 2022; (9(2)) doi:10.3390/children9020188.
PMID: 35204909 - 3
Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.
Yang P, Subbaiah PV
Biochimica et biophysica acta 2015; (1851(10)):1327-36.
PMID: 26193433 - 4
High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
Tani M, Horvath KV, Lamarche B, et al.
Atherosclerosis 2016; (253()):7-14 doi:10.1016/j.atherosclerosis.2016.08.014.
PMID: 27573733 - 5
Primary hypertriglyceridemia in children and adolescents.
Shah AS, Wilson DP
Journal of clinical lipidology 2015; (9(5 Suppl)):S20-8.
PMID: 26343209 - 6
Severe hypertriglyceridemia in Japan: Differences in causes and therapeutic responses.
Murase T, Okubo M, Ebara T, Mori Y
Journal of clinical lipidology 2017; (11(6)):1383-1392 doi:10.1016/j.jacl.2017.08.006.
PMID: 28958672 - 7
Versatile Functions of Hepatic Lipase in Lipoprotein Metabolism.
Dijk W, Rimbert A, Sotin T, et al.
Arteriosclerosis, thrombosis, and vascular biology 2026; (46(1)):105-118 doi:10.1161/ATVBAHA.125.323051.
PMID: 41230597 - 8
Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy.
Reiner Ž
Korean circulation journal 2018; (48(12)):1097-1119 doi:10.4070/kcj.2018.0343.
PMID: 30403015 - 9
Phenotype in Individuals with Heterozygous Rare Variants in LIPC Encoding Hepatic Lipase.
Jacob EO, Wang J, McIntyre AD, Hegele RA
International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111445.
PMID: 39518997 - 10
Can genetic testing help in the management of dyslipidaemias?
Lazarte J, Hegele RA
Current opinion in lipidology 2020; (31(4)):187-193 doi:10.1097/MOL.0000000000000690.
PMID: 32520779
This page is for informational purposes only and does not constitute medical advice. Your healthcare team should interpret your LIPC results, set lipid targets, and explain treatment and pancreatitis warning signs for your situation.